Business Description
Nascent Pharma Holdings Inc
NAICS : 325411
SIC : 2833
ISIN : US63108T1051
Description
Nascent Pharma Holdings Inc has acquired a Subsidiary engaged in enforcing and commercializing the patents held by Nascent. The acquired patents cover liquid formulations of cannabis. The patents relate to the extraction of pharmaceutically active components from plant materials, and more particularly to the preparation of a botanical drug substance for incorporation into a medicament and for use in pharmaceutical formulations, in particular comprising cannabinoids obtained from cannabis. Patented uses include using the liquid formulations to alleviate numerous debilitating conditions, including cancer, irritable bowel syndrome, chronic pain, post-traumatic stress disorder, anxiety, sleep disorders, and opioid dependencies.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 16.86 | |||||
9-Day RSI | 28.19 | |||||
14-Day RSI | 35.36 | |||||
3-1 Month Momentum % | 24.17 | |||||
6-1 Month Momentum % | -6.88 | |||||
12-1 Month Momentum % | -0.67 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | 23.81 | |||||
OCF Margin % | 23.81 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-Forward-Revenue | 0.64 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:NASC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nascent Pharma Holdings Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.033 | ||
| EPS (TTM) ($) | -0.305 | ||
| Beta | 0.1856 | ||
| 3-Year Sharpe Ratio | 0.02 | ||
| 3-Year Sortino Ratio | 0.04 | ||
| Volatility % | 105.83 | ||
| 14-Day RSI | 35.36 | ||
| 14-Day ATR ($) | 0.001008 | ||
| 20-Day SMA ($) | 0.014458 | ||
| 12-1 Month Momentum % | -0.67 | ||
| 52-Week Range ($) | 0.01 - 0.03552 | ||
| Shares Outstanding (Mil) | 90.22 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nascent Pharma Holdings Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nascent Pharma Holdings Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| 0.066667:1 Stock Split | 2022-02-14 | 8.10 (+5.88%) | ||
| 0.003333:1 Stock Split | 2020-03-06 | 34.20 (-15.56%) | ||
| 0.1:1 Stock Split | 2013-06-04 | 688.57 (+0.00%) |
Show
Entries
Nascent Pharma Holdings Inc Frequently Asked Questions
What is Nascent Pharma Holdings Inc(NASC)'s stock price today?
The current price of NASC is $0.01. The 52 week high of NASC is $0.04 and 52 week low is $0.01.
When is next earnings date of Nascent Pharma Holdings Inc(NASC)?
The next earnings date of Nascent Pharma Holdings Inc(NASC) is .
Does Nascent Pharma Holdings Inc(NASC) pay dividends? If so, how much?
Nascent Pharma Holdings Inc(NASC) does not pay dividend.
Guru Commentaries on OTCPK:NASC
No articles.
Press Release
Articles on Nascent Pharma Holdings Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers